Danish Basic Materials Stock News

Embla Medical hf (CPSE:EMBLA) posted earnings forecast to grow at 14.51% per year, with revenue set to rise by 8.5% annually. Both figures are ahead of the Danish market’s expected growth. The company’s net profit margin edged up to 8.6% from 8.2% the year before. While the most recent year’s earnings growth came in at 11.7%, the broader five-year average sits at a robust 19.2% per year. Embla’s combination of faster-than-market growth and steadily improving profitability, coupled with a lack...

Key Insights Significant control over FLSmidth by retail investors implies that the general public has more power to...

GN Store Nord A/S ( CPH:GN ), might not be a large cap stock, but it received a lot of attention from a substantial...

When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...

The main aim of stock picking is to find the market-beating stocks. But even the best stock picker will only win with...

DFDS A/S' ( CPH:DFDS ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment opportunity...

Royal Unibrew (CPSE:RBREW) has kicked off a share buy-back program, beginning August 27 and running until December 19, 2025. This move typically indicates management’s confidence in the company and can influence investor attitudes. See our latest analysis for Royal Unibrew. Despite Royal Unibrew’s new buy-back program hinting at management’s confidence, the stock has lost some momentum lately. Over the past year, the total shareholder return was -7.9%, while the three-year gain was 7.7%,...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

This week we saw the Netcompany Group A/S ( CPH:NETC ) share price climb by 18%. But that can't change the reality that...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

It looks like ChemoMetec A/S ( CPH:CHEMM ) is about to go ex-dividend in the next four days. The ex-dividend date...

Key Insights The projected fair value for FLSmidth is kr.657 based on 2 Stage Free Cash Flow to Equity FLSmidth is...

A lackluster earnings announcement from Harboes Bryggeri A/S ( CPH:HARB B ) last week didn't sink the stock price...

DSV A/S ( CPH:DSV ) received a lot of attention from a substantial price movement on the CPSE over the last few months...

Key Insights The projected fair value for ChemoMetec is kr.554 based on 2 Stage Free Cash Flow to Equity Current share...

While Aktieselskabet Schouw & Co. ( CPH:SCHO ) might not have the largest market cap around , it received a lot of...

Dantax (CPH:DANT) has had a rough three months with its share price down 14%. We decided to study the company's...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

With a price-to-earnings (or "P/E") ratio of 20.3x NTG Nordic Transport Group A/S ( CPH:NTG ) may be sending bearish...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

If you are eyeing H. Lundbeck stock and trying to decide whether now is the right time to move, you are not alone. Investors have noticed the recent uptick, with shares climbing 5.6% in the past week and 12.6% over the last month. Year to date, the return is a solid 6.9%. What really stands out is the 91.1% gain over the past three years. Clearly, the market has warmed up to Lundbeck, giving some the sense that the momentum could continue, or perhaps that all the easy gains are already...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...